ArticleInvestigational new drugs2015

Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer.

Bengt Gustavsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.